The association of depressive symptoms and serum estradiol and testosterone levels in postmenopausal women

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20200720002

Enrollment

165

Registered

2020-07-20

Start date

2020-07-17

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy postmenopausal women Age 50&#45

Interventions

Healthy postmenopausal women 50&#45

65 years who go to hospital for health check up

Diagnostic

Postmenopausal women

Eligibility

Sex/Gender

Female

Age

50 Years to 65 Years

Inclusion criteria

Inclusion criteria: - Natural postmenopausal women, age 50 - 65 years - Visit doctor for health check up

Exclusion criteria

Exclusion criteria: -Receive estrogens or testosterone treatment within 12 months -History or current use of selective serotonin reuptake inhibitor, serotonin norepinephrine reuptake inhibitor, or tricyclic antidepressant -Known or suspected depressive, anxiety disorder, and other neuropsychological diseases -Drug illicit, malnutrition -Presence of hot flushes -Presence of any cancer, severe infection, severe illness or stress

Design outcomes

Primary

Measure	Time frame
Association between depressive symptoms and serum estradiol cross section PHQ 9, HAMD scale,Association between depressive symptoms and serum testosterone cross section PHQ 9, HAMD scale	—

Secondary

Measure	Time frame
Association between anxiety symptoms and serum estradiol cross section HAMA scale,Association between anxiety symptoms and serum testosterone cross section HAMA scale	—

Countries

Thailand

Contacts

Public ContactAmmarin Suwan

Obstetric and Gynecology department, Faculty of Medicine, Chulalongkorn University

whitelabor.sw@gmail.com66819769422

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026